Australia's Leading Ophthalmic Magazine Since 1975

Australia's Leading Ophthalmic Magazine Since 1975

World-renowned surgeon joins Australian eye tech company

24/10/2018 • By Myles Hume

Share

Widely-respected US eye surgeon Dr David Lubeck has been appointed chief medical officer (CMO) of Australian-based Ellex Medical Lasers.

Lubeck – known for his cataract, corneal and refractive surgical work – will drive the clinical and commercial development of the company’s portfolio in interventional ophthalmic treatment technology, including its restorative glaucoma and age-related macular degeneration (AMD) treatments.

US eye surgeon Dr David Lubeck.

Lubeck’s first major assignment will be chairing a roundtable discussion at the American Academy of Ophthalmology meeting in Chicago, discussing the role of Ellex’s proprietary Reflex Technology portfolio in treatment of symptomatic floater patients. He will also highlight Ellex’s breakthrough 2RT Retinal Rejuvenation Therapy for the treatment of intermediate AMD.

“As CMO, I will have the opportunity to act as the voice of both patient and physician within the company as it develops and advances treatment technologies,” Lubeck said.

Lubeck has more than 30 years’ experience in ophthalmology. He is a founder of Arbor Centers for EyeCare in Chicago, where he will continue his work alongside the CMO role for Ellex. During his career he has been responsible for the introduction and advancement of many cutting edge procedures and technologies, regularly being the first to perform complex operations.

His main focus has been making current surgical principles, techniques and instruments accessible to physicians at various levels of experience and practices of all sizes.